AXIOS August 22, 2024
Tina Reed

The Food and Drug Administration approved new formulations of both Moderna and the Pfizer-BioNTech COVID-19 vaccines on Thursday.

Why it matters: The approval comes as the number of COVID infections grows in more than two dozen states and respiratory virus season fast approaches.

State of play: CDC advisers in June recommended that people 6 months of age and older receive updated COVID-19 vaccines when they become available this fall.

  • The new vaccine doses are tailored to the KP.2 strain — a descendant of the highly contagious JN.1 variant. The KP variants account for almost 70% of all current cases in the U.S.
  • Officials said individuals who receive one of these updated...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma / Biotech, Provider, Public Health / COVID
Related Articles:
Marty Makary, Who Made His Name Bashing the Medical Establishment, May Soon Lead FDA
Gutting FDA Won't Make America Healthy
Google’s Pixel Watch 3 Loss of Pulse Detection Feature Receives FDA Clearance
FDA Annual Flu Vaccine Meeting and CDC’s ‘Wild to Mild’ Campaign Canceled
Supporting the Development of Drugs for Rare Diseases — The Importance of Regulatory Transparency

Share This Article